SCHEMBL19852373

SCHEMBL19852373

CCCOC(=O)c1cccnc1C

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.64
P2RX7 Q99572 1/20 0.57
TSHR P16473 7/20 0.51
TDP1 Q9NUW8 4/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
CYP3A4 P08684 2/20 0.50
MAPK1 P28482 2/20 0.50
TP53 P04637 1/20 0.50
LMNA P02545 2/20 0.49
KDM4E B2RXH2 2/20 0.47
KDM4A O75164 1/20 0.47
KDM4C Q9H3R0 1/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 2/20 0.45
ESR1 P03372 1/20 0.44
CHRM1 P11229 1/20 0.44
SLC6A2 P23975 1/20 0.44
KDR P35968 1/20 0.44
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL109206 0.88 TSHR (0.63) ALDH1A1P2RX7TSHRL3MBTL1MAPK1
SCHEMBL29571304 0.88 TSHR (0.63) ALDH1A1P2RX7TSHRL3MBTL1MAPK1
SCHEMBL27977134 0.84 P2RX7 (0.54) ALDH1A1P2RX7TSHRTDP1L3MBTL1
SCHEMBL8407020 0.84 ALDH1A1 (0.64) ALDH1A1TSHRTDP1L3MBTL1CYP3A4
SCHEMBL163355 0.84 ALDH1A1 (0.64) ALDH1A1TSHRTDP1L3MBTL1CYP3A4
SCHEMBL28216192 0.83 P2RX7 (0.60) ALDH1A1P2RX7TSHRTDP1L3MBTL1
SCHEMBL25421430 0.83 ALDH1A1 (0.62) ALDH1A1TSHRTDP1L3MBTL1CYP3A4
SCHEMBL28937318 0.82 P2RX7 (0.58) ALDH1A1P2RX7TSHRTDP1L3MBTL1
SCHEMBL27492813 0.81 ALDH1A1 (0.60) ALDH1A1TSHRTDP1L3MBTL1CYP3A4
SCHEMBL11846633 0.80 ALDH1A1 (0.58) ALDH1A1TSHRTDP1L3MBTL1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3551632-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Leo Pharma A/S (DK) 2019-10-16 EP claimed
WO-2018108910-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS LEO PHARMA A/S (DK) 2018-06-21 WO claimed
EP-3551632-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Leo Pharma A/S (DK) 2019-10-16 EP disclosed
CN-104870422-B Amine derivative or its salt 富士胶片富山化学株式会社 2019-03-15 CN disclosed
WO-2018108910-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS LEO PHARMA A/S (DK) 2018-06-21 WO disclosed
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed
CN-103459384-A Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture EXELIXIS INC 2013-12-18 CN disclosed
CN-102459249-A Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases EXELIXIS INC 2012-05-16 CN disclosed